Our own group has confirmed that treatment with metformin can suppress the self-renewal and proliferation of cancer stem/progenitor cells in HER2 gene-amplified breast carcinomas cells refractory to HER2-targeted drugs [97, 98]. The gene discussed is ERBB2; the disease is breast carcinoma.